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This study determines the results of programmed 
stimulation in patients with syncope or near-syncope 
presumed to have the carotid sinus Syndrome based 
on the finding of carotid sinus hypersensitivity and 
the absence of any other apparent cause for syn- 
cope or near-syncope after clinical evaluation. Four- 
teen patients had coronary artery disease, 1 had di- 
lated cardiomyopathy and 18 patients did not have 
structural heart disease. Programmed simulation 
was performed at 2 basic drive cycle lengths and 2 
right ventricular sites with 1 to 3 extrastimuli. Sus- 
tained unimorphic ventricular tachycardia (VT) was 
induced in 5 of 15 patients tiho had.structural heart 
disease, and in none of the 18 patients who did not 
(p <0.05). Polymorphic VT or ventricular fibrillation 
(VF) was induced in 5 of 15 patiehts (33 % ) who 
had structural heart disease, and in 5 of 18 patients 
(27%)” who did not (p >0.05). Patients who had 
inducible unimorphic VT were treated with antiar- 
rhythmic drugs that suppressed the induction of VT, 
and 4 of 5 patients also received a pacemaker; no 
patient had a recurrence of syncope during fofiow- 
up. Patients who had inducible polymorphii VT and 
VF (n = 10) or no inducible VT (n = 18) received 
treatment directed at only carotid sinus syndrome. 
Two patients with inducible VT or VF and 1 patient 
without inducible VT had recurrent syncope during 
follow-up, but none had cardiac arrest or died srid- 
deniy. it is concluded that programmed stimulation 
should be performed in patients presumed to have 
carotid sinus syndrome who have structural heart 
disease; unimorphic VT may be induced in one-third 
of these patients, raising the possibility that VT fs 
the cause of syncope. Antiarrhythmic drug therapy 
may be unnecessary if pdymorphic VT or VP is in- 
duced. in patients without heart disease, pro- 
grammed stimulation is highly unlikely to yield a 
clinically significant arrhythmia. 
(Am J Cardioi 1987;60:1073-1077}‘, 
, 
A patient who has had syncope may be presumed to 
have the carotid sinus syndrome if clinical evaluation 
demonstrates carotid hypersensitivity and no other ap- 
parent cause for sjmcope. However, clinical symptoms 
of syncope or near-syncope infrequently are repro- 
duced by carotid sinus massage.l Furthermore, carotid 
sinus hypersensitivity is associated with coronary ar- 
tery disease2 and an abnormal electrocardiogram,3 
and more than one-half of patients who have carotid 
hypersensitivity never have had syncope.2,4 Therefore, 
carotid sinus hypersensitivity may be an incidental 
finding unrelated to cerebral symptoms in patients 
who have had syncope or near-syncope, particular- 
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ly in those who have structural heart disease. Pro- 
grammed ventricular stimulation has been found to be 
useful in uncovering ventricular tachycardia (VT) as a 
potential cause of syncope in patients with unex- 
plained syncope. 5-13 However, prior studies of pro- 
grammed ventricular stimulation ip patients with un- 
explained syncope have either excluded patients witk 
carotid sinus hypersensitivity or included only a small 
number of such patients. lo-l2 Therefore, little data are 
available on the value of programmed ventricular 
stimulation in patients with syncope who have carotid 
sinus hypersensitivity. This study determines the re- 
sults of programmed ventricular stimulation in pa- 
tients with syncope or near-syncope and a presump- 
tive diagnosis of carotid sinus syndrome. We wished to 
define the role of programmed ventricular stimulation. 
in patients with presumed carotid sinus syndrome. 
Methods 
Characteristics of patients studied: The study 
group consisted of 28 men and 5 women with a history 
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of syncope (28 patients) or near-syncdpe (5 patients] 
whose mean age (& 1 standard deviation) was 66 f 10 
years The mean number of episodes of syncope or 
near-syncope was 2.3 f 1.4. In each patient; a pre- 
sumptive diagnosis of carotid sinus syndrome was 
based on the presence of carotid sin& hypersensitivity 
during carotid sinus massage, and the absence of any 
other apparent cause of syncope after a complete neu- 
rologic and noninvasive cardiac evaluation. Fourteen 
patients had corqnary artery disease, 1 patient had an 
idiopathic dilated cardiomyopathy, and 18 patients did 
not have clinical evidence of structural heart disease. 
All patients underwent at least 24 hours of continu- 
ous ambulatory electrocardiographic monitoring be- 
fore undergoing an electrophysiologic study. Pre- 
mature ventricular complexes were present in 24 pa- 
tients, and 6 patients were found to have nonsustained 
VT (maximal duration 5 beats), but no patient had 
cerebral symptoms during monitoring?’ ’ 
Left ventridular ejection fraction was measured in 
27 patients by either a radionuclide or contrast ventric- 
ulogram, or &dimensional echocardiogram. Left ven; 
tricular ejection fraction was normal (more than O.$O] 
in 17 patients and abnormal in 10 patients who had a 
mean ejection fraction of 0.33 f ‘0.11. 
Electrophysiologic study protocol: After informed 
consent was obtained, patients weie, studied in the 
fasting, insedated state. Antiarrhythgic drug therapy 
was discontinued at least 4 half-lives before the elec- 
trophysiologic study. Quadripolar electrode catheters 
were inserted percutaneously in a femoral vein and 
positioned in the high right atrium, across the tricuspid 
valve to record the His bundle electrogram, against the 
right ventricular apex, and at either the right ventricu- 
lar outflow tract or septum. A ihort cannula was insert- 
ed into a femoral artery for continuous monitoring of 
the arterial pressure. Electrocardidgraphic leads V1, I 
+d III, the intracardiac electrograms; and the arterial 
pressure tracing were record’ed at a paper speed df 25 
to 100 mm/s on an Electronics for Medicine VR-12 or 
Siemens-Elema Minograf: 7 recorder. Programmed 
stimulation was performed with a programmable stim- 
ulator (Bloom Associtites, Ltd.]. The stimuli were 2 ms 
in duration and twice diastolic threshold. 
Method of carotid sin~+~ massage: Carotid sinus 
massage was performed with~the patient supine during 
the course of electrophysiologic study; Carotid bruits 
were ruled out before carotid Sinus massage. The ex- 
aminer identified the fusiform carotid sinus or the area 
of greatest arterial pulsation lying anterior to the ster- 
nomastoid muscle at the upper border of the thyroid 
cartilage. Vigorous massage was performed for 5 sec- 
onds during continuous electrdcardiographic and he- 
modynamic monitoring. After the heart rate and arte- 
rial pressure had returned to baseline values, the 
contralateral carotid sinus was massaged. If carotid 
sinus hypersensitivity was present, massage &as re- 
peated to. assure reproducibility. 
Patients were considered to have carotid sinus hy- 
persensitivity if 1 of the 3 follpwing responses occurred 
during carotid sinus massage? (1) cardioinhibitory re- 
sponse; more than 3 seconds of asystole, with minimal 
decrease in arterial pressure when carotid massage 
was repeated during ventricular pacing at a rate of 70 
beats/min; (2) vasodepressor respqnse; a decrease of 
50 mm Hg or more in the systolic arterial pressure, 
without a significant chtinge in heart rate; or (3) a 
mixed response. 
Atrial stimulation: The sinus node recovery time, 
atrioventricular conduction and the inducibility of su- 
praventricular tachycardia were assessed by incre- 
mental atria1 pacing and the atria1 extrastimulus tech- 
nique. In no patient was a potential cause of syncope 
uncovered by atria1 pacing. 
Programmed ventricular stimulation protocol: 
The programmed ventricular stimulation protocol has 
been described in detail previously.14 In brief, at least 
2 basic drive cycle lengths were used (600, 500 or 400 
ms). The basic drive trains were 8 beats in duration. 
Programmed stimulation with single and double ‘extra- 
stimuli was performed at the right ventricular apex, 
then at the right ventricular outflow tract or septum. If 
necessary, programmed stimulation with triple extra- 
stimuli was then performed at the 2 right ventricular 
sites. Nonsustained VT was defined as VT 6 beats to 30 
seconds in duration. Sustained VT was defined as VT 
lasting more than 30 seconds or requiring direct-cur- 
rent countershock. Electropharmacologic testing was 
performed in patients who had inducible sustained 
unimorphic VT. * 
Follow-up evaluation: All patients were seen peri- 
odically as otitpatients or were contacted by telephone 
and were questioned about recurrences of syncbpe oi 
near-syncope. 
Statistical analysis: Statistical analyses were per- 
formed with Student t test or Fisher exact test. A p 
value <0.05 was considered statistically significani. 
Results 
Response to carotid sinus ma&age: Seventeen pa- 
tients had a cardioinhibitory response to carotid sinus 
massage, with a mean asystolic interval qf 5.6 f 1.3 
seconds. Four patients had a vasodepressor response 
to carotid sinus massage, with a inean decrease in sys- 
tolic arterial pressure at 76 f 13 mm Hg. Twelve pa- 
tients had a mixed response. 
Results of programmed ventricular stimulation: 
Unimorphic sustained VT (mean cycle length 274 f 49 
ms] was induced by programmed stimulation with 
double extrastim@ in 4 patients and with triple extra: 
stimuli in 1 patient (Table I]. Sustained VF was in- 
duced in 1 patient by .triple extrastimuli. Sustained 
polymorphic VT or ventricular flutter with a mean 
cycle length of 197 f 15 ms was induced in 2 patients 
by programmed stimulation with triple extrastimuli 
and in 1 patient with double extrastimuli. Polymorphic 
nonsustained VT [cycle length 224 f 28 ms and mean 
duration 6.3 & 4.8 seconds] was induced in 6 patients 
by programmed stimulation with triple extrastimuli 
[Table II). 
Comparison of patients with and without structur- 
al heart disease: Sustained unimorphic VT was in- 
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TABLE I Clinical Characteristics and Follow-Up in Patients with Inducible Unimorphic Sustained Venirlcular Tachycardia 
Age (yr) Duration of 












LVEF VT Morphology CL (ms) AA Therapy Follow-Up (mo) 
0.20 RBBB superior 360 A + PP 1 
0.36 RBBB superior 260 A + PP 7 
0.54 LBBB superior 260 A + PP 12 
0.48 LBBB superior 250 Quinidine 16 
0.40 I inferior 240 Proc + PP 5 
A = amiodarone; AA = antiarrhythmici CAD = coronary artery disease; CHF = congestive heart failure: CL = cycle length; DC = dilated cardiomypathy; I 
= indeterminant; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; Proc = procainamide; PP = permanent pacemaker; qBl3B = 
right bundle branch block; VT = ventricular tachycardia. 





















0.29 Poly, NS 
ND Poly, NS 
0.40 Poly, NS 
0.19 V flutter 
0.70 VF 
0.51 Poly, S 
ND Poly, NS 
0.89 Poly, s 
>0.50*. Poly, NS 






















ND = not done; NS = nonsustained; Poly = polymorphic; S = sustained; VF = ventricular fibrillation; Other abbreviations as in Table I. 
duced in, 5 of 15 patients who had structural heart 
disea;se, and in none of 18 patients who did not have 
structural heart disease (p <O.O5]. Polymorphic VT or 
VF was induced in 5 of 15 patients (33%] who had 
structural heart disease and in 5 of 18 patients (27%) 
who did not (p X.05). 
Coniparison of patients with and without induci- 
ble unimorphic ventricular tachycardia: In the group 
of 15 patients who had structural heart disease, the 5 
patients in whom sustained unimorphic VT was in- 
ducible were compared with 10 patients in whom uni- 
morphic VT was not inducible. There were no signifi- 
cant differences between the 2 groups of patients in 
age or left ventricular ejection fraction. The patients in 
whom unimorphic VT was induced did not have a 
higher incidence of Q waves or bundle branch block 
on the electrocardiogram. 
Treatment: A permanent pacemaker was implant- 
ed in 18 patients who had a cardioinhibitory response 
to carotid sinus massage and a history of either fre- 
quent episodes of syncope, syncope while driving or 
injury caused by syncope. A permanent pacemaker 
was not implanted in 15 patients because of either the 
presence of a significant vasodepressor component 
during carotid sinus massage or a history of only near- 
syncope and not syncope. 
Among the 5 patients who had inducible unimor- 
phic sustained VT, 1 patient was treated with quini- 
dine, 1 with procainamide and 3 with amiodarone. In 
each patient, the antiarrhythmic drug therapy w& ef- 
fective in suppressing the induction of VT. Four of 
these 5 patients also underwent implantation of a per- 
manent pacemaker. No patient in whom polymorphic 
VT or VF was induced was treated with antiarrhyth- 
mic drugs. 
Follow-up: Among the 5 patients who had induci- 
ble unimorphic VT, 1 patient died from congestive 
heart failure after 1 month of follow-up and 4 patients 
have remained alive over a mean follow-up duration 
of 10 f 4 months [range 5 to 16). No patient had synco- 
pe, near-syncope, cardiac arrest or sudden death dur- 
ing follow-up (Table I). 
Among the 10 patients who had inducible polymor- 
phic VT or VF, the mean duration of follow-up was 15 
f 7 months (range 2 to 261 (Table II]. One patient died 
from pneumonia. Two patients had a recurrence of 
syncope. In 1 of these patients, who had a vasodepres- 
sor response to carotid sinus massage, the features of 
the syncopal episode were characteristic of vaso- 
depressor syncope. The second patient who had a re- 
currence of syncope had undergone implantation of a 
dual chamber pacemaker, and in this patient, the 
cause of the recurrent syncope was unclear. No patient 
in this group had a cardiac arrest or died suddenly 
during the follow-tip period. 
Eighteen patients without inducible arrhythmias 
were followed for a mean duration of 13 f 8 months 
(range 2 to 31) (Table III). One patient died from non- 
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& Sex Heart Disease LVEF AA Therapy 
Duration of 
Follow-Up (mo) 
16 59/M CAD ND PP 2 
17 d/M CAD 0.20 0 7 
18 46/M CAD 0.72 0 16 
19 79/M CAD 0.31 PP 19 
20 72/M CAD 0.75 PP 31 
21 72/F 0 ND PP ‘3 
i2 75/F 0 >0..50* 0 5 
23 7pM 0 0.47 0 ri 
24 59/M 0 0.52 PP 9 
25 63/M 0 ND 0 10 
26 72/M 9 >OSO” PP 13 
$7 61/M 0 >0.50” PP 13 
28 58/M 0 >b.so* PP 14 
?9 44/M 0 0.79 0 13 
30 51/M 0 b-0.50’ 0 15 
31 72&I 0 ND 0 16 
32 72/M 0 >0.50* 0 23 
33 86/F 0 0.73 0 31 
l Echocardiographic determination. 
Abbreviations as in Tables I and II. 
cardiac causes. One patient had recurrent syncope. No 
patient in this group had a cardiac arrest or died sud- 
denly during the follow-up period. . 
bilcc us&M ’ ’ 
Ma of programmid ventricular stimulatjon in 
patiefits ptesumed to have carotid sinus syndrome: 
The results of this study suggest that programmed ven- 
tridular stimulation may play an important role in the 
management of some patients with syncope or near- 
syrmope who are presumed to have the carotid sinus 
syndrome based on the finding of carotid sinus hyper- 
sensitivity and the absence of any other likely cause of 
ayticope after a neurologic and noninvasive cardiac 
evaluation! Among patients with structural heart dis- 
ease but no clinical evidence of VT as the cause of 
syn6pe, programmed ventricular stimulation may re- 
sult fn the jnduction of sustained unimorphic VT in 
onehthird of patients. 
inducible sustained unimorphic’VT has been dem- 
onstrated to be a clinically important finding in prior 
studies of patients with unexplamed syncope.*Jl 
Accordingly, patients in this study who had induci- 
ble unimorphic VT were treated’with antiarrhythmic 
drugs demonstrated during electropharmacologic test- 
ing to be effective in suppressing the induction of VT. 
This antiarrhythmic drug therapy may have contrib- 
uted to prevention of recurrent syncope during the 
follotv-up period. Because programmed’ ventricular 
stimulation may uncover a second potential cause for 
syncope in up to one-third of patients with syncope 
and carotid sinus hypersensitivity who have structural 
heart disease, programmed ventricular stimulation is 
appropriate in these patients, unless the diagnosis 
of carotid sinus syndrome has been established by 
electrodardiographic monitoring during a spontaneous 
episode of syncope. 
None of the 18 patients in this study who did not 
have structural heart disease were found to have in- 
ducible sustained &morphic VT. Similarly, in prior 
studies of electrophysiologic testing in patients with 
unexplained syncope, sustained unimorphic VT was a 
rare finding in patients without structural heart dis- 
ease.5-12 Therefore, because programmed ventricular 
stimulation is likely to have an extremely low yield of 
clinically important VT in patients without underlying 
heart disease who are presumed to have the carotid 
sinus syndrome, programmed ventricular stimulation 
need not be performed in these patients unless there is 
a specific reason to suspect VT as the cause of syncope 
based on the history or results of electrocardiographid 
monitoring. 
Patients with structuril heart disease most likely 
to have inducible unimorphic ventricular tachycar- 
dia: Analysis of clinical variables demonstrated that 
among the 15 patients with structural heart disease, 
there were no significant differences between the pa- 
tients who had inducible unimorphic VT and those 
who did not. Therefore, it may not be possible to pre- 
dict on the basis of clinical evaluation which patients 
with structural heart disease and presumed carotid 
sinus syndrome are likely to have inducible unimor: 
phic >VT. Unless the diagnosis of carotid sinus syn- 
drome has been established on clinical grounds in- 
stead of being a presumptive diagnosis, programmed 
ventricular stimulation should be considered in all pa- 
tients who have structural heart disease. 
Significance of polymorphic ventricular tachycpr- 
dia and ventricular fibrillation: Prior studies in pa- 
tients with and without structural heart disease vi;ho 
either were asymptomatic or had a history of unex: 
plained syncope have demonstrated that inducible 
polymorphic VT and VF in these patients most likely 
represent a laboratory artifact devoid of clinical signif- 
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icance.8J1J5-20 Therefore, the patients in this study 
who had inducible polymorphic VT or VF were not 
treated with antiarrhythmic drugs. Although 2 of these 
patients had a recurrence of syncope, the historical 
details in 1 patient were typical of vasodepressor syn- 
cope. None of these patients died suddenly or had 
symptomatic VT during follow-up. This suggests that 
inducible polymorphic VT or VF may not have any 
prognostic significance in this patient group and may 
not necessarily be an indication for antiarrhythmic 
drug therapy. 
Results of previous studies: In 3 prior reports, a 
total of 23 patients who had syncope or near-syncope 
and carotid hypersensitivity underwent programmed 
ventricular stimulation with up to z extrastimuli.lO-12 
In contrast to the results of the present study, polymor- 
phic VT was induced in only 2 of these 23 patients and 
unimorphic VT was induced in only 1. The higher 
incidence of inducible polymorphic VT in the present 
study undoubtedly is related to the use of triple extra- 
stimuli. However, 4 of the 5 unimorphic VTs in the 
present study were induced by 2 extrastimuli; there- 
fore the higher incidence of inducible unimorphic VT 
cannot be attributed to our use of more extrastimuli. 
Prior reports did not always specify which patients 
with carotid hypersensitivity had structural heart dis- 
ease. Therefore, it is possible that the higher incidence 
of inducible unimorphic VT in the present study is 
related to a higher incidence of structural heart disease 
in our patient group. 
Limitations: The major limitation of this study is 
one that is inherent to all studies of patients with unex- 
plained syncope. Because none of the patients in this 
study was undergoing electrocardiographic monitor- 
ing at the time of syncope, the diagnosis of unimorphic 
VT as the cause of syncope on the basis of electrophys- 
iologic testing was presumptive and not based on de- 
finitive evidence. Although prior studies have demon- 
strated that inducible sustained unimorphic VT is an 
unusual finding in patients who have not had unimor- 
phic VT,15-17 we cannot rule out the possibility that 
sustained unimorphic VT was an incidental finding 
unrelated to syncope in the patients in this study. Be- 
cause of a possible risk of sudden death, this study did 
not include a control group of patients who had induci- 
ble sustained unimorphic VT and were not treated 
with antiarrhythmic drugs. Furthermore, because 4 of 
5 patients who had inducible sustained unimorphic 
VT and were treated with antiarrhythmic drugs also 
underwent implantation of a permanent pacemaker, it 
cannot be determined whether the lack of recurrent 
syncope during follow-up was attributable to the anti- 
arrhythmic drugs, the pacemaker, or both. 
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